OmRx Oncology, Inc.

OmRx Oncology is a pioneering biopharmaceutical company focused on expanding access to life-saving cancer treatments. Our work begins with OX-4224, a small molecule checkpoint inhibitor designed to overcome barriers in regions where traditional antibody-based immunotherapies are out of reach.